Current recommendations from the Infectious Diseases Society of America (IDSA) suggest vancomycin, linezolid, or daptomycin combined with piperacillin / tazobactam, a carbapenem, ceftriaxone plus metronidazole, or a fluoroquinolone plus metronidazole.